Indices
Indxx Global Generics & New Pharma Index
The Indxx Global Generics & New Pharma Index provides exposure to the 40 largest companies involved in manufacturing Generics, SuperGenerics, Biobetters and Biosimilars, and providing API manufacturing, CMO and CRO services to the pharmaceutical industry. The index has been backtested to March 18, 2005 and has a live calculation date of November 13, 2015.
IGNRXT
2023-03-24 00:00:00-3967.8504239111000
Powered By
Back-tested performance is hypothetical and has certain inherent limitations. Back-tested performance differs from live performance and is included for informational purposes only.
Back-tested performance is hypothetical and has certain inherent limitations. Back-tested performance differs from live performance and is included for informational purposes only.
Index Characteristics
| Base Date | 03/21/2005 |
| No. of Constituents | 22 |
| Dividend Yield * |
1.03% |
| 52 Week High/Low ** |
4608/3416 |
* Trailing 12 months data for current year portfolio
** Trailing 12 months
Top 5 Index Constituents
| Company Name | Weight(%) |
|---|---|
| Samsung Biolog Ord | 8.48% |
| Lonza Group Ord | 7.98% |
| Iqvia Holdings Ord | 6.74% |
| Icon Ord | 6.33% |
| Celltrion Ord | 6.15% |
Index Risk & Return Statistics
| Statistic | QTD | YTD | 1 Year | 3 Year | Since Base Date |
|---|---|---|---|---|---|
| Beta 1 |
NA | NA2 | NA | NA | NA |
| Correlation 1 |
NA | NA | NA | NA | NA |
| Returns 2 |
-1.81% | -1.81% | -11.01% | 12.64% | 7.95% |
| Standard Deviation | 14.61% | 14.61% | 20.16% | 17.08% | 15.04% |
1W.R.T.: Indxx 500 Index TR
2As of last trading day.